Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

An expert review on advances in noninvasive tests for NAFLD recognizes cT1 as a validated tool for detecting NASH and at-risk NASH, correlating with NAS features and fibrosis. cT1 showed the highest rule-in specificity (90%) among the reviewed noninvasive tests for at-risk NASH at a cut-off of ≥ 875 ms.